EPO 20000 UNT/ML Injectable Solution [Epogen]
- RxCUI
- 212218
- RxNorm name
- EPO 20000 UNT/ML Injectable Solution [Epogen]
- Display name
- EPO 20000 UNT/ML Injectable Solution [Epogen]
- Full name
- EPO 20000 UNT/ML Injectable Solution [Epogen]
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103234 | Epogen/Procrit | epoetin alfa | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EPOGEN | EPOETIN ALFA | Amgen, Inc | 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 212218 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 | EPO 20000 UNT/ML Injectable Solution [Epogen] | SY | 136 | These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN . EPOGEN ® (epoetin alfa) i njection , for intravenous or subcutaneous use Initial U.S. Approval: 1989 | 20251105 |
| 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 | epoetin alfa 20000 UNT/ML Injectable Solution [Epogen] | SBD | 136 | These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN . EPOGEN ® (epoetin alfa) i njection , for intravenous or subcutaneous use Initial U.S. Approval: 1989 | 20251105 |
| 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 | Epogen 20000 UNT/ML Injectable Solution | SY | 136 | These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN . EPOGEN ® (epoetin alfa) i njection , for intravenous or subcutaneous use Initial U.S. Approval: 1989 | 20251105 |
| 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 | ERYTHROPOIETIN 20000 UNT/ML Injectable Solution [Epogen] | SY | 136 | These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN . EPOGEN ® (epoetin alfa) i njection , for intravenous or subcutaneous use Initial U.S. Approval: 1989 | 20251105 |
| 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 | EPOGEN 20,000 UNT/ML Injectable Solution | PSN | 136 | These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN . EPOGEN ® (epoetin alfa) i njection , for intravenous or subcutaneous use Initial U.S. Approval: 1989 | 20251105 |
| 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 | Epogen (epoetin alfa 20,000 UNT/ML) Injectable Solution | SY | 136 | These highlights do not include all the information needed to use E POGEN safely and effectively. See full prescribing information for E POGEN . EPOGEN ® (epoetin alfa) i njection , for intravenous or subcutaneous use Initial U.S. Approval: 1989 | 20251105 |